ArQule | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ArQule

An SI Board Since December 1996

Posts	SubjectMarks	Bans	Symbol
399	14	0	ARQL

Emcee: noronha	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
349	Nice syllogism, Rick. And probably placed correctly-:) ARQL may have delivere	John Metcalf	-	7/22/1999
348	ARQL is to SEPR as Dell is to your butt. Striking parallels? They both work w	scaram(o)uche	-	7/22/1999
347	ARQL is similar to ABSC in that PFE just announced a long term deal. These de	Biotech Jim	-	7/22/1999
346	New to thread. ARQL has some striking parallels to that investment darling SEP	Herc	-	7/21/1999
345	Rumor has it that the news is not over yet, look for another contract news rele	RealTime	-	7/21/1999
344	biz.yahoo.com Wednesday July 21, 10:30 am Eastern Time Arqule , Pfizer in $117	Rigorous	-	7/21/1999
343	2Q ended June 30th. Should be any day now. Regards.	FigureOuter	-	7/20/1999
342	does anyone know when the next quarterly report for ARQL is due to be filed?	RealTime	-	7/8/1999
341	StockDoc, ARQL is very closed mouthed at the moment. they keep saying that by y	Dr. John M. de Castro	-	7/6/1999
340	Thanks for the note. We might eventually get back to "rational" drug	StockDoc	-	7/4/1999
339	Thanks for the link. It's one of the clearest overviews I've seen.	Rigorous	-	6/28/1999
338	Biospace.com published a fine combichem article. I picked this up off of a Yaho	Dr. John M. de Castro	-	6/25/1999
337	Entering preclinical tox studies indicates that the molecule(s) is manufactured	StockDoc	-	5/12/1999
336	The compound is from a directed array. These are developed out of a "hit&q	Dr. John M. de Castro	-	5/7/1999
335	Agreed. What I wish they had emphasized (if only to validate my reading of the	tommysdad	-	5/6/1999
334	It did trip a milestone payment to ARQL. So it was a legitimate item to announc	Dr. John M. de Castro	-	5/6/1999
333	<<There has never been a combinatorial chemistry molecule that reached th	tommysdad	-	5/6/1999
332	ARQL Milestone - Molecule selected for development biz.yahoo.com There has ne	Dr. John M. de Castro	-	5/6/1999
331	Dr.Voodoo thanks for the thoughtful post. Along the same lines as your ideas, I	Dr. John M. de Castro	-	4/23/1999
330	tommysdad, nice thoughts. I'd add that IMHO ARQL has acquired a vast amount	Dr. John M. de Castro	-	4/23/1999
329	>>>>"focus on those with greatest potential" <<<	Dr. Voodoo	-	4/22/1999
328	Can I take a shot at these? 1) Too many biotechs have an uncertain future. By	tommysdad	-	4/22/1999
327	Interesting quote from the Q1 results news release. 1) "focus on those wi	Dr. John M. de Castro	-	4/22/1999
326	Not gonna happen. Pfizer has a big internal combichem effort and just dropped	tommysdad	-	4/21/1999
325	ARQL Q1 results. $4 million loss. Ugh!! I guess you could call this choppy. It	Dr. John M. de Castro	-	4/21/1999

Go to reply# or date (mm/dd/yy):